May 06, 2016 4:17 AM ET

Biotechnology

Company Overview of miRagen Therapeutics, Inc.

Company Overview

miRagen Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of microRNA (miRNA)-targeting therapies to improve human health in disease areas of high unmet medical need. It offers miR-208, a heart-specific miRNA that protects the stressed heart from maladaptive changes and preserves cardiac function; and miR-15/195 inhibitors to reduce heart muscle cell death and promote heart muscle cell regeneration following myocardial infarction or heart attack. The company also provides miR-145, a regulator of vascular smooth muscle cells, which focuses on application in hypertension and other vascular diseases to reduce pathological vascular remodeling and lower blo...

6200 Lookout Road

Suite 100

Boulder, CO 80301

United States

Founded in 2006

Phone:

303-531-5952

Fax:

303-531-5094

Key Executives for miRagen Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Co-Founder and Chairman of The Board
Age: 41
Co-Founder and Member of Scientific Advisory Board
Co-Founder and Member of the Scientific Advisory Board
Age: 70
Co-Founder and Director
Age: 75
Compensation as of Fiscal Year 2015.

miRagen Therapeutics, Inc. Key Developments

miRagen Therapeutics, Inc. Initiates First Clinical Trial for MRG-106 in Lymphoma Patients

miRagen Therapeutics, Inc. announced that it has initiated a Phase 1 clinical study of its anti-cancer product candidate MRG-106, a synthetic microRNA antagonist (LNA antimiR®) of microRNA-155. The Phase 1 trial is being conducted in patients suffering from cutaneous T-cell lymphoma (CTCL) of the mycosis fungoides (MF) sub-type.

Joshua Resnick to Join miRagen Board of Directors

Joshua Resnick, president of MRL Ventures, will join the miRagen board of directors.

miRagen Therapeutics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-12-2015 10:20 AM

miRagen Therapeutics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-12-2015 10:20 AM. Venue: Le Parker Meridian, 119 West 56th Street, New York, NY 10019, United States.

Similar Private Companies By Industry

Company Name Region
Gamma Biologicals, Inc. United States
Biofilm Technologies, Inc. United States
NeuroCorp., Ltd. United States
Morphogenesis, Inc. United States
Exicure Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 30, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact miRagen Therapeutics, Inc., please visit www.miragentherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.